Factor V Leiden and the Risk for Venous Thromboembolism in the Adult Danish Population

Annals of Internal Medicine

Volumn 140, Issue 5, 2004, Pages

  Juul, Klaus ^b   Tybjærg Hansen, Anne ^b   Schnohr, Peter ^b   Nordestgaard, Børge G ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CASE CONTROL STUDY; DEATH; DEEP VEIN THROMBOSIS; DENMARK; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK; RISK ASSESSMENT; RISK FACTOR; SMOKING; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 1442357145     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-140-5-200403020-00008     Document Type: Article

References (27)

1. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA. 1997;277:1305-7. [PMID: 9109469]
2. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133-4. [PMID: 7475606]
3. Leroyer C, Mercier B, Escoffre M, Ferec C, Mottier D. Factor V Leiden prevalence in venous thromboembolism patients. Chest. 1997;111:1603-6. [PMID: 9187182]
4. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85:1504-8. [PMID: 7888671]
5. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912-7. [PMID: 7877648]
6. Cattaneo M, Chantarangkul V, Taioli E, Santos JH, Tagliabue L. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G 1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels. Thromb Res. 1999;93:1-8. [PMID: 10065893]
7. Gaustadnes M, Rudiger N, Moller J, Rasmussen K, Bjerregaard Larsen T, Ingerslev J. Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients. Blood Coagul Fibrinolysis. 1999;10:251-9. [PMID: 10456616]
8. Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol. 1999;19:511-8. [PMID: 10073951]
9. Turkstra F, Karemaker R, Kuijer PM, Prins MH, Buller HR. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different? Thromb Haemost. 1999;81:345-8. [PMID: 10102457]
10. Martinelli I, Cattaneo M, Panzeri D, Mannucci PM. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism. Thromb Haemost. 1997;77:440-3. [PMID: 9065990]
11. Juul K, Tybjaerg-Hansen A, Steffensen R, Kofoed S, Jensen G, Nordestgaard BG. Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. Blood. 2002;100:3-10. [PMID: 12070000]
12. Simioni P, Prandoni P, Lensing AW, Scudeller A, Sardella C, Prins MH, et al. The risk of recurrent venous thromboembolism in patients with an Arg506→ Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med. 1997;336:399-403. [PMID: 9010145]
13. Appleyard M, Tybjærg-Hansen A, Jensen G, Schnohr P, Nyboe J. The Copenhagen City Heart Study: Osterbroundersogelsen: a book of tables with data from the first examination (1976-78) and a five year follow-up (1981-1983). Scand J Soc Med Suppl. 1989;170(Suppl 41):1-160.
14. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M. The Copenhagen City Heart Study-Tables with data from the third examination 1991-1994. Eur Heart J. 2001;3(Suppl H):1-83.
15. Jensen G. Epidemiology of chest pain and angina pectoris. Acta Med Scand Suppl. 1984;1-120.
16. Manten B, Westendorp RG, Koster T, Reitsma PH, Rosendaal FR. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation. Thromb Haemost. 1996;76:510-3. [PMID: 8902987]
17. Margaglione M, Brancaccio V, Giuliani N, D'Andrea G, Cappucci G, Iannaccone L, et al. Increased risk for venous thrombosis in carriers of the prothrombin G→A20210 gene variant. Ann Intern Med. 1998;129:89-93. [PMID: 9669991]
18. Chamouard P, Pencreach E, Maloisel F, Grunebaum L, Ardizzone JF, Meyer A, et al. Frequent factor II G20210A mutation in idiopathic portal vein thrombosis. Gastroenterology. 1999;116:144-8. [PMID: 9869612]
19. Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood. 1999;93:906-8. [PMID: 9920839]
20. Aznar J, Vaya A, Estelles A, Mira Y, Segui R, Villa P, et al. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Haematologica. 2000;85:1271-6. [PMID: 11114134]
21. de Moerloose P, Reber G, Perrier A, Perneger T, Bounameaux H. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. Br J Haematol. 2000;110:125-9. [PMID: 10930988]
22. Desmarais S, de Moerloose P, Reber G, Minazio P, Perrier A, Bounameaux H. Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet. 1996;347:1374-5. [PMID: 8637344]
23. Meyer G, Emmerich J, Helley D, Arnaud E, Nicaud V, Alhenc-Gelas M, et al. Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. Am J Med. 2001;110:12-5. [PMID: 11152859]
24. Bounameaux H. Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism. Lancet. 2000;356:182-3. [PMID: 10963193]
25. Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet. 2001;109:369-84. [PMID: 11702218]
26. Larsen TB, Lassen JF, Brandslund I, Byriel L, Petersen GB, Norgaard-Pedersen B. The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns. Thromb Res. 1998;89:211-5. [PMID: 9645914]
27. Hille ET, Westendorp RG, Vandenbroucke JP, Rosendaal FR. Mortality and causes of death in families with the factor V Leiden mutation (resistance to activated protein C). Blood. 1997;89:1963-7. [PMID: 9058717]